We are live on !
Find out more
Absolute Return Capital Portfolio holdings
AUM
$1.57B
Turnover
38.81%
1-Year Est. Return
6.36%
This Fund
S&P 500
This Quarter Est. Return
-8.38%
1 Year Est. Return
-6.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.57B
AUM Growth
-$942M
(-38%)
Cap. Flow
-$750M
Cap. Flow % of AUM
Cap. Flow %
-47.93%
Top 10 Holdings %
Top 10 Hldgs %
14.15%
Holding
675
New
91
Increased
134
Reduced
278
Closed
171
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$18.6M |
| 2 |
Chevron
CVX
|
+$13.2M |
| 3 |
Union Pacific
UNP
|
+$12.9M |
| 4 |
Exelon
EXC
|
+$11.5M |
| 5 |
RTX Corp
RTX
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$23.4M |
| 2 |
Eli Lilly
LLY
|
+$21.4M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$19.8M |
| 4 |
Cigna
CI
|
+$18.9M |
| 5 |
Hasbro
HAS
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.26% |
| 2 | Energy | 14.73% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Consumer Staples | 10.31% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Edwards Lifesciences
EW
$51B
| $315K | 0.02% |
13,314
-97,020
| -88% | -$2.34M |
2013 Q3
8 quarters
|
|
402
Voya Financial
VOYA
$8.73B
| $315K | 0.02% |
8,114
+2,272
| +39% | +$100K |
2014 Q1
6 quarters
|
|
403
Markel Group
MKL
$23.2B
| $313K | 0.02% |
390
+34
| +10% | +$28.8K |
2014 Q1
6 quarters
|
|
|
JCP
404
DELISTED
J.C. Penney Company, Inc.
JCP
| $312K | 0.02% |
33,555
-38,623
| -54% | -$342K |
2013 Q3
8 quarters
|
|
|
IM
405
DELISTED
Ingram Micro
IM
| $306K | 0.02% |
11,219
-1,312
| -10% | -$34.1K |
2013 Q2
9 quarters
|
|
406
DELISTED
Triumph Group
TGI
| $303K | 0.02% |
7,204
+3,543
| +97% | +$190K |
2013 Q3
8 quarters
|
|
407
DELISTED
VCA Inc.
WOOF
| $297K | 0.02% |
5,638
-7,048
| -56% | -$395K |
2014 Q1
6 quarters
|
|
408
Reliance Steel & Aluminium
RS
$21.5B
| $287K | 0.02% |
5,315
+3,510
| +194% | +$205K |
2013 Q2
9 quarters
|
|
409
Carlisle Companies
CSL
$13.5B
| $285K | 0.02% |
3,260
-3,915
| -55% | -$391K |
2015 Q1
2 quarters
|
|
|
ANAT
410
DELISTED
American National Group, Inc. Common Stock
ANAT
| $285K | 0.02% |
2,917
+2,411
| +476% | +$248K |
2015 Q2
1 quarter
|
|
411
Hyatt Hotels
H
$16.8B
| $284K | 0.02% |
6,035
-2,507
| -29% | -$134K |
2013 Q3
8 quarters
|
|
|
VER
412
DELISTED
VEREIT, Inc.
VER
| $277K | 0.02% |
+7,177
| New | +$300K |
2015 Q3
0 quarters
|
|
413
SBA Communications
SBAC
$18.4B
| $275K | 0.02% |
2,626
-8,794
| -77% | -$1.02M |
2014 Q3
4 quarters
|
|
|
CYT
414
DELISTED
CYTEC INDS INC
CYT
| $264K | 0.02% |
+3,574
| New | +$249K |
2015 Q3
0 quarters
|
|
415
Bunge Global
BG
$19.6B
| $263K | 0.02% |
3,582
+2,089
| +140% | +$162K |
2014 Q3
4 quarters
|
|
416
Cullen/Frost Bankers
CFR
$9.7B
| $261K | 0.02% |
4,108
+2,612
| +175% | +$178K |
2014 Q4
3 quarters
|
|
417
DELISTED
Theravance Biopharma
TBPH
| $260K | 0.02% |
23,701
-25,375
| -52% | -$323K |
2014 Q2
5 quarters
|
|
418
AGNC Investment
AGNC
$10.4B
| $259K | 0.02% |
13,854
-70,785
| -84% | -$1.36M |
2013 Q2
9 quarters
|
|
|
HDS
419
DELISTED
HD Supply Holdings, Inc.
HDS
| $258K | 0.02% |
+9,009
| New | +$302K |
2015 Q3
0 quarters
|
|
420
TFS Financial
TFSL
$4.6B
| $253K | 0.02% |
+14,651
| New | +$248K |
2015 Q3
0 quarters
|
|
|
FCE.A
421
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $249K | 0.02% |
12,345
-18,680
| -60% | -$412K |
2015 Q1
2 quarters
|
|
|
MNK
422
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $246K | 0.02% |
3,847
-6,703
| -64% | -$664K |
2013 Q3
8 quarters
|
|
|
DISCK
423
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $245K | 0.02% |
10,084
-196,812
| -95% | -$5.46M |
2015 Q1
2 quarters
|
|
424
Interactive Brokers
IBKR
$38.7B
| $243K | 0.02% |
24,652
-11,276
| -31% | -$116K |
2014 Q2
5 quarters
|
|
425
United Airlines
UAL
$33B
| $241K | 0.02% |
4,539
-5,081
| -53% | -$287K |
2014 Q4
3 quarters
|
|
Similar funds
AH
GHF
Absolute Return Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Absolute Return Capital held 675 positions worth $1.57B, down 38% from $2.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Absolute Return Capital withdrew a net $750M in Q3 2015, closing 171 positions and reducing 278 holdings. Its most notable exit was Eli Lilly, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 16% a quarter earlier, followed by Energy and Consumer Discretionary.
Against the trend, Absolute Return Capital opened a new position in Exelon worth $10.8M.
- Absolute Return Capital's largest Q3 2015 buy was Exelon: 510,763 shares worth $10.8M.
- Absolute Return Capital added most to ExxonMobil in Q3 2015, an estimated $18.6M increase.
- Absolute Return Capital's biggest Q3 2015 reduction was Brown-Forman Class B, cutting an estimated $23.4M.
- Absolute Return Capital fully exited Eli Lilly in Q3 2015, selling an estimated $21.4M.
- Absolute Return Capital's ten largest holdings make up 14% of its $1.57B portfolio in Q3 2015.
- Absolute Return Capital opened 91 new positions and closed 171 in Q3 2015.
- Absolute Return Capital's portfolio value fell 38% quarter-over-quarter to $1.57B.
Based on Absolute Return Capital's 13F filing for Q3 2015, filed 13 Nov 2015.